New drugs entering the market face specific challenges posed by increasing payer budget constraints and evolving regulatory requirements.

Our experts’ strong understanding of the global payer landscape can help you shape your market access strategy and develop compelling content to convey your product’s economic and clinical value to healthcare decision-makers.

Our services include:

  • Value propositions
  • Core value dossiers
  • Evidence reviews
  • Systematic literature reviews
  • Identification of unmet medical needs
  • HTA reviews
  • Gap analysis
  • SWOT analysis
  • Payer landscaping
  • KOL engagement
  • HTA submissions